Cargando…
436. Developing a Synthetic DNA Vaccine for an Emerging Pathogen - Middle East Respiratory Syndrome
Autores principales: | Reuschel, Emma L., Muthumani, Karrupiah, Kraynyak, Kim, Tingey, Colleen, Kudchodkar, Sagar B., Khan, Amir S., Sardesai, Niranjan Y., Kim, J. Joseph, Maslow, Joel, Park, Young K., Kobinger, Gary, Falzarano, Darryl, Feldman, Heinrich, Weiner, David B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Gene & Cell Therapy. Published by Elsevier Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129814/ http://dx.doi.org/10.1016/S1525-0016(16)33245-2 |
Ejemplares similares
-
A synthetic consensus anti-Spike protein DNA vaccine induces protective immunity against Middle East Respiratory Syndrome Coronavirus in non-human primates
por: Muthumani, K., et al.
Publicado: (2016) -
Rapid response to an emerging infectious disease – Lessons learned from development of a synthetic DNA vaccine targeting Zika virus
por: Kudchodkar, Sagar B., et al.
Publicado: (2018) -
Co-Administration of Molecular Adjuvants Expressing NF-Kappa B Subunit p65/RelA or Type-1 Transactivator T-bet Enhance Antigen Specific DNA Vaccine-Induced Immunity
por: Shedlock, Devon J., et al.
Publicado: (2014) -
Novel prostate cancer immunotherapy with a DNA-encoded anti-prostate-specific membrane antigen monoclonal antibody
por: Muthumani, Kar, et al.
Publicado: (2017) -
Synthetic DNA Vaccines: Improved Vaccine Potency by Electroporation and Co-Delivered Genetic Adjuvants
por: Flingai, Seleeke, et al.
Publicado: (2013)